<code id='AE9F391473'></code><style id='AE9F391473'></style>
    • <acronym id='AE9F391473'></acronym>
      <center id='AE9F391473'><center id='AE9F391473'><tfoot id='AE9F391473'></tfoot></center><abbr id='AE9F391473'><dir id='AE9F391473'><tfoot id='AE9F391473'></tfoot><noframes id='AE9F391473'>

    • <optgroup id='AE9F391473'><strike id='AE9F391473'><sup id='AE9F391473'></sup></strike><code id='AE9F391473'></code></optgroup>
        1. <b id='AE9F391473'><label id='AE9F391473'><select id='AE9F391473'><dt id='AE9F391473'><span id='AE9F391473'></span></dt></select></label></b><u id='AE9F391473'></u>
          <i id='AE9F391473'><strike id='AE9F391473'><tt id='AE9F391473'><pre id='AE9F391473'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:9928
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more
          BioAge raises $170M for combination therapy with Zepbound
          BioAge raises $170M for combination therapy with Zepbound

          Illustration:STAT;Source:EliLilly/APACaliforniabiotechdevelopingacombinationtherapywiththeobesitydru

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

          1:03JackSmith,thentheDepartmentofJustice'schiefofthePublicIntegritySection,posesforphotoattheDepartm